Drugs / Budesonide/Formoterol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00868426 | Apr → May 2009 | — | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide/Formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00868426 ↗ |
| Route | Inhaled | “Single, inhaled dose” NCT00868426 ↗ |